SCHEMBL6793443

SCHEMBL6793443

CCc1ccc(-c2ccccc2C(=O)Nc2ccc(N(CCc3cccc(NC(=O)OC(C)(C)C)n3)C(=O)O)cc2)cc1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MTTP P55157 5/20 0.39
CYP17A1 P05093 1/20 0.37
POLB P06746 1/20 0.37
GAA P10253 1/20 0.37
ADRB1 P08588 1/20 0.37
ADRB3 P13945 1/20 0.37
NR1H4 Q96RI1 1/20 0.37
ALDH1A1 P00352 3/20 0.37
LTB4R2 Q9NPC1 2/20 0.37
PTGER2 P43116 1/20 0.37
NPC1 O15118 2/20 0.36
MEN1 O00255 1/20 0.36
HPGD P15428 1/20 0.36
HTT P42858 1/20 0.36
KMT2A Q03164 1/20 0.36
RAB9A P51151 1/20 0.36
SMN1; SMN2 Q16637 1/20 0.36
SMO Q99835 1/20 0.36
SREBF2 Q12772 1/20 0.36
CHRNB2 P17787 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6796042 0.94 MTTP (0.36) MTTPCYP17A1POLBGAANR1H4
SCHEMBL6793653 0.92 POLB (0.38) MTTPPOLBGAAALDH1A1LTB4R2
SCHEMBL6788433 0.91 GAA (0.49) MTTPPOLBGAANR1H4ALDH1A1
SCHEMBL6800939 0.88 GAA (0.42) POLBGAANR1H4ALDH1A1HTT
SCHEMBL6788594 0.87 NPC1 (0.43) MTTPCYP17A1POLBGAAADRB1
SCHEMBL6498208 0.86 CYP17A1 (0.37) CYP17A1POLBALDH1A1NPC1HPGD
SCHEMBL6800937 0.85 BCL2 (0.37) MTTPCYP17A1POLBGAACHRNB2
SCHEMBL6647849 0.84 ALDH1A1 (0.36) GAAALDH1A1NPC1HTTRAB9A
SCHEMBL6792697 0.84 MTTP (0.45) MTTPGAASMN1; SMN2SMO
SCHEMBL6794786 0.82 POLB (0.38) MTTPPOLBGAAALDH1A1NPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20040058903-A1 Benzamide compounds as apo b secretion inhibitors FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2004-03-25 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040058903-A1 Benzamide compounds as apo b secretion inhibitors APOB, APOL1, SCARB1 MTTP 363/4885CYP17A1 1309/4885POLB 1470/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.